Scientific article
Open access

The wearable cardioverter-defibrillator: current technology and evolving indications

Published inEuropace, vol. 19, no. 3, p. 335-345
Publication date2017

The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach.

  • Arrhythmias
  • Cardiac/economics/mortality/physiopathology/therapy
  • Cost-Benefit Analysis
  • Death
  • Sudden
  • Cardiac/prevention & control
  • Defibrillators/economics
  • Diffusion of Innovation
  • Electric Countershock/adverse effects/economics/instrumentation/mortality
  • Equipment Design
  • Health Care Costs
  • Humans
  • Patient Compliance
  • Patient Satisfaction
  • Risk Factors
  • Treatment Outcome
Citation (ISO format)
REEK, Sven et al. The wearable cardioverter-defibrillator: current technology and evolving indications. In: Europace, 2017, vol. 19, n° 3, p. 335–345. doi: 10.1093/europace/euw180
Main files (1)
Article (Published version)
ISSN of the journal1099-5129

Technical informations

Creation11/19/2018 4:34:00 PM
First validation11/19/2018 4:34:00 PM
Update time03/15/2023 3:16:07 PM
Status update03/15/2023 3:16:05 PM
Last indexation10/19/2023 9:42:38 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack